Chronic Thromboembolic Pulmonary Hypertension (CTPH) is associated with the formation of fibrotic material that obstructs large pulmonary arteries, thereby causing persistence shortness of breath. It is responsible for significant morbidity and mortality. According to one study, 3.8% patient with acute pulmonary embolus will develop CTPH.
Proper management of CTPH patient would reduce the mortality rate. In this exclusive interview, Dr. Julius Punnen shares his views and experience about the management of Chronic Thromboembolic Pulmonary Hypertension.
